Neurocrine Biosciences | 销售成本

Cost Of Sales 更改 日
AbbVie USD 4.09B 181M 2024-03
Acadia Pharmaceuticals USD 22.95M 5.06M 2024-03
Agios Pharmaceuticals USD 627K 41K 2024-03
ALKERMES USD 58.64M 11.48M 2024-03
Alnylam Pharmaceuticals USD 65.98M 19.88M 2024-03
Amgen USD 3.2B 88M 2024-03
Biogen USD 542.2M 76.1M 2024-03
BioMarin Pharmaceutical USD 125.18M 10.3M 2024-03
Dynavax Technologies USD 10.97M 2.28M 2024-03
Exelixis USD 21.26M 2.48M 2024-03
Gilead Sciences USD 1.55B 59M 2024-03
Halozyme Therapeutics USD 28.33M 23.97M 2024-03
Incyte USD 61M 3.05M 2024-03
Intra Cellular Therapies USD 9.9M 802K 2024-03
Ionis Pharmaceuticals USD 2.15M 911K 2024-03
Neurocrine Biosciences USD 7.5M 3.7M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Repligen USD 76.39M 11.74M 2024-03
Sarepta Therapeutics USD 50.56M 13.53M 2024-03
Teva Pharmaceutical Industries USD 2.05B 88M 2024-03
Ultragenyx Pharmaceutical USD 17.53M 5.48M 2024-03
Vertex Pharmaceuticals USD 342.6M 23.9M 2024-03



Neurocrine Biosciences 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.